待处理
入排:排除
图源:待检查
Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma.
Thomas Powles, Toni K Choueiri, Robert J Motzer, Eric Jonasch, Sumanta Pal, Nizar M Tannir, Sabina Signoretti, Rajesh Kaldate, Christian Scheffold, Evelyn Wang, Dana T Aftab, Bernard Escudier, Daniel J George
BMC Cancer 21(1) 1023
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板